×
About 3,215 results

ALLMedicine™ Disseminated Intravascular Coagulation Center

Research & Reviews  1,125 results

Elevated serum amylase affects clinical outcomes in COVID-19
https://www.mdedge.com/gihepnews/article/249267/exocrine-pancreatic-insufficiency/elevated-serum-amylase-affects-clinical

Dec 1st, 2021 - Key clinical point: Elevated serum amylase (ESA) was associated with adverse clinical outcomes and mortality in hospitalized patients with COVID-19. Major finding: Hyperamylasemia (amylase > upper limit of normal [ULN] of 115 U/L) was independentl.

A Case of Tumor Lysis Syndrome Complicated by Disseminated Intravascular Coagulation - ...
https://www.ncbi.nlm.nih.gov/pubmed/34846374
Rhode Island Medical Journal (2013); Morito L, Meehan-Cousee K et. al.

Dec 1st, 2021 - Hematologic/Oncologic emergencies are rarely seen in the critical care transport environment but must be recognized and treated without delay. We report such a patient transported from a referring hospital to a tertiary care center by the LifePACT...

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia.
https://doi.org/10.1016/S2213-2600(21)00455-0
The Lancet. Respiratory Medicine; Vincent JL, Levi M et. al.

Nov 29th, 2021 - A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19, with an increased risk of thromboembolic complications. The inflammatory response to SARS-CoV-2 infection can cause an acute-phase response and endothelial dysfun...

Cytokine storm after heart transplantation in COVID-19-related haemophagocytic lymphohi...
https://doi.org/10.1002/ehf2.13728
ESC Heart Failure; Mahdavi M, Hejri GM et. al.

Nov 26th, 2021 - While severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily causes inflammation in the respiratory system, there is growing evidence of extrapulmonary tissue damage mediated by the host innate immune system in children a...

Thrombotic Microangiopathy Triggered by COVID-19: Case Reports.
https://doi.org/10.1159/000520144
Nephron Korotchaeva J, Chebotareva N et. al.

Nov 23rd, 2021 - SARS-CoV-2 causes thrombotic microangiopathy (TMA) through the activation of an alternative and lectin complement pathway. TMA is one of the main reasons for acute kidney injury development in patients with COVID-19. In this study, we present 3 TM...

see more →

Guidelines  3 results

Practice Bulletin No. 183 Summary: Postpartum Hemorrhage.
https://doi.org/10.1097/AOG.0000000000002346
Obstetrics and Gynecology;

Sep 25th, 2017 - Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality wor...

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the It...
https://doi.org/10.1016/j.thromres.2011.08.028
Thrombosis Research; Di Nisio M, Baudo F et. al.

Sep 21st, 2011 - The diagnosis and treatment of disseminated intravascular coagulation (DIC) remain extremely controversial. The Italian Society for Thrombosis and Haemostasis commissioned a project to develop clinical practice guidelines for the diagnosis and tre...

Guidelines for the diagnosis and management of disseminated intravascular coagulation. ...
https://doi.org/10.1111/j.1365-2141.2009.07600.x
British Journal of Haematology; Levi M, Toh CH et. al.

Feb 19th, 2009 - The diagnosis of disseminated intravascular coagulation (DIC) should encompass both clinical and laboratory information. The International Society for Thrombosis and Haemostasis (ISTH) DIC scoring system provides objective measurement of DIC. Wher...

see more →

Drugs  59 results see all →

Clinicaltrials.gov  23 results

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
https://clinicaltrials.gov/ct2/show/NCT04505774

Oct 29th, 2021 - The severe acute respiratory syndrome coronavirus 2, which causes the highly contagious coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. The clinical spectrum of COVID-19 infection is broad, encompassing asymptomatic infecti...

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
https://clinicaltrials.gov/ct2/show/NCT04367831

Sep 29th, 2021 - Hemostatic, biomarker, and inflammatory changes are common in severe manifestations of coronavirus disease 2019 (COVID-19).Such factors, as well as the bedridden status and critical illness may constitute a prothrombotic milieu, predisposing to ve...

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation
https://clinicaltrials.gov/ct2/show/NCT04345848

Sep 14th, 2021 - The ongoing COVID-19 pandemic affects millions of humans worldwide and has led to thousands of acute medical hospitalizations. There is evidence that hospitalized cases often suffer from an important infection-related coagulopathy and from elevate...

COVID-19 Infection and Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04492371

Aug 19th, 2021 - Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), is a highly contagious disease that appeared in Wuhan, Hubei province of China in December 2019. It has now spread to multiple countries through infected persons trav...

Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients
https://clinicaltrials.gov/ct2/show/NCT04366960

Jun 8th, 2021 - Coronavirus disease-19 (COVID-19 ), which is caused by SARS-CoV-2 infection, are apparently at high risk of venous thromboembolism (VTE), as a consequence of activation of the hemostatic system which, in the most severe cases, can also be associat...

see more →

News  76 results

Elevated serum amylase affects clinical outcomes in COVID-19
https://www.mdedge.com/gihepnews/article/249267/exocrine-pancreatic-insufficiency/elevated-serum-amylase-affects-clinical

Dec 1st, 2021 - Key clinical point: Elevated serum amylase (ESA) was associated with adverse clinical outcomes and mortality in hospitalized patients with COVID-19. Major finding: Hyperamylasemia (amylase > upper limit of normal [ULN] of 115 U/L) was independentl.

Checkpoint Inhibitors Show Promise in Triple-Negative Breast Cancer
https://www.onclive.com/view/checkpoint-inhibitors-show-promise-in-triple-negative-breast-cancer

Oct 6th, 2021 - Rita Nanda, MD Immune checkpoint inhibitors can be of significant value in combatting recurrent and metastatic triple negative breast cancer (TNBC), Rita Nanda, MD, told physicians at the recent 14th Annual International Congress on the Future of...

Dr. Mims on Waiting for Molecular Tests Before Starting Therapy in AML
https://www.onclive.com/view/dr-mims-on-waiting-for-molecular-tests-before-starting-therapy-in-aml

Oct 6th, 2021 - Alice S. Mims, MD, medical oncologist, Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center—James, discusses her recommendations regarding holding therapy until molecular test results are r...

Targeted Therapy Approvals Spur Increased Biomarker Research in AML
https://www.onclive.com/view/targeted-therapy-approvals-spur-increased-biomarker-research-in-aml

Oct 6th, 2021 - Alice Mims, MD The introduction of targeted therapies in acute myeloid leukemia (AML) has motivated research efforts dedicated to identifying biomarkers in the newly diagnosed and relapsed/refractory settings to better find optimal treatments for...

AZ COVID Vaccine: Causal Link to Severe Thrombosis Established
https://www.medscape.com/viewarticle/949108

Apr 12th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two scientific studies establishing a causal relationship between the AstraZeneca COVID-19 vaccine and severe thrombotic complications have now be...

see more →